Explores a regulatory campaign to promote access to antibiotics in the U.S. during the 1950s. Amendment to the Food and Drug Act; Findings of an economic study of the pharmaceutical industry conducted by the Federal Trade Commission; Controversies surrounding antibiotics access in the country.